FDA Approved: APREPITANT — Supplemental Application (Sandoz Inc)

View source ↗

Summary

The FDA approved Sandoz Inc's supplemental application for aprepitant, enabling a generic version for prevention of chemotherapy-induced nausea and vomiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• Aprepitant (aprepitant)

Snippet

SUPPL AP for APREPITANT (APREPITANT)